source
- Pfizer sells Seagen-derived ADC to Medicus Pharma for $12 million upfront, potential $1 billion milestonesPfizer has transferred rights to an antibody‑drug conjugate it acquired in its Seagen purchase to Medicus Pharma. Medicus will pay $12 million upfront and $15 million a year later, and Pfizer coul…
- Former Pfizer chemist launches Khartis Therapeutics with $95M to develop oral thyroid eye disease drugRobert Hoffman, a veteran Pfizer chemist who previously co‑founded XinThera, announced the launch of Khartis Therapeutics. The new company, formed in 2024 with other former XinThera leaders, aims t…